NCT02038751

Brief Summary

The growing evidence showed that the OSA is a heritable complex genetic disease where the genetic basis contributed the development of OSA and its sequel. The phenotyping of OSA include high level and intermediate level. The former indicates the AHI, and later includes craniofacial morphology, ventilator control, obesity, and sleepiness vulnerability. Many studies tried to determine the association of candidate genes with OSA through association studies. However, the results were conflicting. We identified 37 candidate genes involved in six biologic pathways of OSA reported in previous literatures, including oxidative phosphorylation, cell signaling, apoptosis, cellular adhesion and motility, cell cycle, and cytokine/chemokine. To investigate the association between phenotype and genotype of OSA, we conducted this cross-sectional study by recruiting the patients of moderate-severe OSA (index proband) and their first and second-degree family members, and friends and their family members (control family) and using candidate genes reported in the literature and whole genome SNP array for genotype approach.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
360

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

January 15, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 17, 2014

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

January 17, 2014

Status Verified

January 1, 2014

Enrollment Period

2.9 years

First QC Date

January 15, 2014

Last Update Submit

January 16, 2014

Conditions

Keywords

GenotypingPhenotypingSleep ApneaGenetic Association StudiesPhenotype

Outcome Measures

Primary Outcomes (2)

  • Family aggregation of OSA and its phenotype

    Phenotypes assessment by PSG, craniofacial image, Hypercapnic ventilatory response testing, psychomotor vigilance task, MSLT, blood biochemistry testing, abdominal MRI, and 24 hr ambulatory BP monitor Family aggregation assessed by family-based study design (1. to compare risk of OSA between index and control proband; 2. to compare risk between index proband with more than one families suffering OSA and without; 3. to calculate inter-generation and intra-generation association index of AHI)

    within the first half year after enrollment

  • Association between phenotype and genotype of OSA

    Genotypes assessed by candidate genes identification or whole genome SNP array Phenotypes assessment by PSG, craniofacial image, Hypercapnic ventilatory response testing, psychomotor vigilance task, MSLT, blood biochemistry testing, abdominal MRI, and 24 hr ambulatory BP monitor Association assessed by linkage study and association study

    within the first half year after enrollment

Study Arms (4)

Index proband

moderate to severe OSA (AHI\>30 or AHI\>15 needing CPAP intervention) age 20-99 y/o

Index family

first-degree, second-degree, or spouse of index proband age \>20 y/o

Control proband

friends of index proband, living in the same environment as index proband age \> 20 y/o

Control family

first-degree, second-degree, or spouse of control proband age \>20 y/o

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

moderate to severe OSA from primary care clinic friends and families from recommendation of OSA patients

You may qualify if:

  • all participants needing age \> 20 y/o
  • Index proband: OSA diagnosed by overnight polysomnography (AHI\>30 or AHI\>15 needing therapeutic intervention)
  • Index family: first-degree, second-degree relatives, or spouse of index proband
  • Control proband: friends recommended by index proband, who lived in the same environment as index proband
  • Control family: first-degree, second-degree relatives, or spouse of control proband

You may not qualify if:

  • Severe CHF, COPD, CKD
  • Psychiatric disorder who can't coordinate to receive evaluation
  • Autoimmune disorders
  • Other sleep disorders
  • Refusing to anticipate or involving other study at the same time

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center of sleep disorders, National Taiwan University Hospital

Taipei, 100, Taiwan

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

whole blood and serum

MeSH Terms

Conditions

Sleep Apnea, ObstructiveSleep Apnea Syndromes

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Peilin Lee, M.D, Ph.D.

    Center of sleep disorders, National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Peilin Lee, M.D, Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2014

First Posted

January 17, 2014

Study Start

January 1, 2014

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

January 17, 2014

Record last verified: 2014-01

Locations